Over-the-counter (OTC) derivatives
Isda AGM: 2011 Margin Survey shows decrease in collateral agreements
Survey released today in Prague also shows increases in portfolio reconciliation
Isda AGM: Esma committed to G-20 clearing deadline, says Maijoor
New authority will conduct cost-benefit analysis to decide which derivatives should be cleared - but G-20 deadline is not negotiable, says Esma chair in first public speech
Isda AGM: regulators must work together to avoid fragmented market, warns Credit Suisse’s Rohner
Institutions will be weaker and markets will be riskier if new rules vary between jurisdictions, Credit Suisse vice-chair warns
Isda raises concerns over Russian netting laws
Despite the challenges involved, banks and brokers are excited by the progress being made to open up the Russian market
Risk Europe: More clearing members preferable, say buy-side panellists
A wider universe of clearing members could help reduce risk, say buy-side representatives – who add they would consider joining
Risk Europe: Expanding the scope of Emir needs careful consideration, says Pearson
A Council of the European Union proposal to expand the scope of new European market infrastructure regulation to include exchange-traded derivatives should be carefully thought through, says the EC’s Patrick Pearson
Collateral management: Firms face up to regulatory challenge
Balancing the books
Algorithmic trading in energy
The hare and the tortoise
EU Council questions Esma’s power to determine clearing eligibility
Legal precedent suggests European Commission might have to determine which contracts should be cleared under new derivatives rules, rather than Esma as originally planned
Funding and pricing OTC derivatives proves treacherous in Australia
Treacherous path ahead
OpRisk North America: Moving OTC trades onto CCPs will increase op risks
Moving OTC trades onto CCPs will increase op risks
European politicians row over scope of Emir
Challenging Emir
Polish OTC clearer aims for 2012 launch as Europe fragments
Another central counterparty plans to launch in Europe, starting with zloty-denominated interest rate swaps
CME names Everaert OTC head
Michael Everaert has joined CME Group as head of OTC solutions
Multi-dealer platforms gear up for credit e-trading adoption
Electronic ambitions
Dealers fear client data leaks via repositories and regulators
Names of derivatives counterparties and deal details could wind up in the public domain, unless regulators are bound by data controls, industry argues
Legal patchwork inhibits progress on derivatives counterparty disclosure
New regulatory fixes only a partial solution as industry anticipates jurisdiction shopping by secretive clients
European Parliament has neglected FX exemption question, says UK MEP
Kay Swinburne criticises colleagues in the European Parliament for failing to tackle the question of whether forex contracts need to be subjected to new clearing and reporting requirements
Counterparty risk management at Asian asset managers found wanting
Institutional investors in Asia have some way to go to meet on-going regulatory requirements as set out by Dodd-Frank, the European Commission and other initiatives aimed at mitigating risks inherent with over-the-counter derivatives, a BNY Mellon survey…
Proof of exposure required before Indian companies can trade derivatives
New regulations will require Indian companies to prove they have an exposure that needs to be hedged
Global supervisors gather at NY Fed for OTC meet
Regulators and supervisors head to Liberty Street for eighth OTC derivatives gathering
FCIC report: the major findings
Risk summarises the major conclusions from the commission report
Isda's Richard Metcalfe: Regulatory risk has many faces
Insightful trading
Asia to follow US on clearing amid fears about hedging costs for exporters
Asian banks likely to opt for harmonised OTC clearing approach with the US and expect higher hedging costs for corporates